O20 Opportunities and challenges experienced when treating HCV in people who inject drugs (PWID) through a nurse-led outreach model

• K. Allardice,
• S. Von Bibra,
• J.S. Doyle,
• P.M. Dietze,
• P. Desmond,
• M. Stoove,
• E. McBryde,
• P. Higgs,
• A.J. Thompson,
• M.E. Hellard

Affiliations

K. Allardice

Disease Elimination Program, Burnet Institute, Australia

S. Von Bibra

Disease Elimination Program, Burnet Institute, Australia

J.S. Doyle

Disease Elimination Program, Burnet Institute, Australia; Department of Infectious Diseases, Alfred and Monash University, Australia

P.M. Dietze

Disease Elimination Program, Burnet Institute, Australia; School of Population Health and Preventive Medicine, Monash University, Australia

P. Desmond

Department of Medicine, University of Melbourne, Australia; Department of Gastroenterology, St Vincent‘s Health, Australia

M. Stoove

Disease Elimination Program, Burnet Institute, Australia; School of Population Health and Preventive Medicine, Monash University, Australia

E. McBryde

Disease Elimination Program, Burnet Institute, Australia; Department of Medicine, University of Melbourne, Australia; Australian Institute of Tropical Health and Medicine, James Cook University, Australia

P. Higgs

Disease Elimination Program, Burnet Institute, Australia; School of Population Health and Preventive Medicine, Monash University, Australia; Department of Public Health, La Trobe University, Australia

A.J. Thompson

Department of Medicine, University of Melbourne, Australia; Department of Gastroenterology, St Vincent‘s Health, Australia

M.E. Hellard

Disease Elimination Program, Burnet Institute, Australia; Department of Infectious Diseases, Alfred and Monash University, Australia; School of Population Health and Preventive Medicine, Monash University, Australia